Back
Akari Therapeutics PLC Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
40
AKTX
Akari Therapeutics PLC
Last Price:
2.23
Seasonality Move:
-3.74%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.46 | Sell |
| 20-day SMA: | 2.49 | Sell |
| 50-day SMA: | 2.98 | Sell |
| 200-day SMA: | 2.57 | Sell |
| 8-day EMA: | 2.46 | Sell |
| 20-day EMA: | 2.55 | Sell |
| 50-day EMA: | 2.82 | Sell |
| 200-day EMA: | 3.04 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 43.98 | Sell |
| Chaikin Money Flow: | 19777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.29 - 2.89) | Sell |
| Bollinger Bands (100): | (2.71 - 3.71) | Sell |
Akari Therapeutics PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 2.43 while AKTX 8-day simple moving average is 2.46, which is a Sell signal.
- The stock price of AKTX is 2.43 while Akari Therapeutics PLC 20-day SMA is 2.49, which makes it a Sell.
- Akari Therapeutics PLC 50-day simple moving average is 2.98 while AKTX share price is 2.43, making it a Sell technically.
- AKTX stock price is 2.43 and Akari Therapeutics PLC 200-day simple moving average is 2.57, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
40
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a Sell
The current Akari Therapeutics PLC [AKTX] share price is $2.43. The Score for AKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
29.05M
Price in USD:
2.43
Share Volume:
39.55K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
1.08
Sell
40
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?
The Akari Therapeutics PLC stock price is 2.43 USD today. -
Will AKTX stock go up or go down?
Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Akari Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 2.43 while AKTX 8-day exponential moving average is 2.46, which is a Sell signal.
- The stock price of AKTX is 2.43 while Akari Therapeutics PLC 20-day EMA is 2.55, which makes it a Sell.
- Akari Therapeutics PLC 50-day exponential moving average is 2.82 while AKTX share price is 2.43, making it a Sell technically.
- AKTX stock price is 2.43 and Akari Therapeutics PLC 200-day simple moving average is 3.04, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics PLC
Is Akari Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
- AKTX Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Akari Therapeutics PLC is a Sell
- Akari Therapeutics PLC Relative Strength Index (RSI) is 43.98, which suggest Akari Therapeutics PLC is oversold
- The Bollinger Bands (25) for Akari Therapeutics PLC is (2.29 - 2.89), which suggest Akari Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Akari Therapeutics PLC is (2.71 - 3.71), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.